University of Michigan Health System - link
Department of Internal Medicine - link
NEPHROLOGY
search this site
 
 
Diane M. Cibrik, M.D., M.S.

Research Summary:

  • The effect of gender on rejection and allograft outcome.
  • The natural history of lymphoma and HPV in the transplant population.
  • Kidney cell infection with BKV
  • New drug development and pharmacokinetics in transplantation

Link to PubMed Citations

Selected Publications:

Luan FL, Zhang H, Schaubel DE, Miles CD, Cibrik D, Norman S, Ojo AO. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant. 2008 Sep; 8(9):1871-7.

Park JM, Lake KD, Cibrik DM. Impact of Changing from Cyclosporine to Tacrolimus on Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients with Diabetes. Ther Drug Monit. 2008 Aug 14; accepted.

Chan L, Greenstein S, Hardy M, Hartmann E, Bunnapradist S, Cibrik D, Shaw LM, Munir L, Ulbricht B, Cooper M. Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. Transplantation 2008 Mar 27; 85(6): 821-6.

Norman, SP, Cibrik, DM. Non-infectious Complications of Kidney Transplantation. Kidney Transplantation: State of the Art, Second Edition, Donald Hricik, Editor. Remedica Publishing. 2007, Chapter 9, pp 165-186.

Luan FL , Miles CD, Cibrik DM, Ojo AO. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation 2007 Aug 27; 84(4): 541-4.

Cibrik DM, Meier-Kriesche HU, Bresnahan B, Wu YM, Klintmalm G, Kew CE, Kuo PC, Whelchel J, Cohen D, Baliga P, Akalin E, Benedetti E, Wright F, Lieberman B,Ulbricht B, Jensik S; Myfortic-US01 Renal Transplant Study Group. Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients. Clin Transplant. 2007 Mar-Apr 21(2):192-201.

Tedesco-Silva H, Pescovitz MD, Cibrik DM, Rees MA, Mulgaonkar S, Kahan BD, Gugliuzza KK, Rajagopalan PR, Esmeraldo Rde M, Lord H, Salvadori M, Slade JM; FTY720 Study Group. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation. Transplantation. 2006 Dec 27;82(12):1689-97.

Luan FL , Chopra P, Park J, Norman SP, Cibrik DM, Ojo AO. Efficacy of Oral Valganciclovir in the Treatment of Primary CMV Infection in Kidney and/or Pancreas Transplant Recipients. Transplant Proceedings 2006 December 38(10):3673-5.

Arns W, Cibrik DM, Walker R, Mourad G, Budde K, Mueller EA, and Vincenti F. Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation: Review of the Literature. October, 2006. Transplantation 82(8):1004-12.

Brennan DC, Daller JA, Lake KD , Cibrik DM, Del Castillo D, for the Thymoglobulin Induction Study Group. Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation. October, 2006. The New England Journal of Medicine 355:19, 1967-77.

Cibrik DM. Management of Post-transplant Recurrent Renal Disease. Graft 2005 March; 7 (2): 107-115.

 
     
   

U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright Regents of the University of Michigan
Template developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index